LVW Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

LVW Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25,000	Closed	-$103K	–	253
2022 Q1	$103K	Hold	25,000	–	–	0.02%	232
2021 Q4	$89K	Hold	25,000	–	–	0.02%	239
2021 Q3	$91K	Hold	25,000	–	–	0.02%	235
2021 Q2	$109K	Hold	25,000	–	–	0.02%	221
2021 Q1	$103K	Hold	25,000	–	–	0.02%	210
2020 Q4	$100K	Hold	25,000	–	–	0.02%	198
2020 Q3	$68K	Buy	+25,000	New	+$69.2K	0.02%	198

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

LVW Advisors's ATRS Position: Q2 2022 in Review

LVW Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 25,000 shares — an estimated $103K sold.

LVW Advisors first reported a position in ATRS in Q3 2020 and held it in 7 quarters. The position peaked at $109K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

LVW Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
LVW Advisors sold 25,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $103K.
LVW Advisors first reported a position in Antares Pharma, Inc. in Q3 2020 and held it in 7 quarters.
LVW Advisors's Antares Pharma, Inc. position peaked at $109K in Q2 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on LVW Advisors's 13F filing for Q2 2022, filed 22 Jul 2022.